Visit website

A daily B2B news website for the pharmaceutical manufacturing industry.’s editorial team attend leading pharmaceutical industry tradeshows to meet the key decision-makers and discover the latest trends and need-to-know news impacting all aspects of worldwide drug production, including:

  • innovations in API processing
  • breakthroughs in delivery technologies
  • the latest regulatory developments
  • trends in QA and QC 

Key Contacts

Melissa Fassbender Editor Tel: +1312 2848590 Email: 

Latest industry news from

More news


ACG expands in Latin American with announcement of its Brazilian capsule plant

ACG announces plans to grow its Latin American presence with its newest capsule production plant in Brazil, as it continues to expand its facilities in Asia-Pacific and Europe.


‘Simply unacceptable’: FDA warns against illegitimate opioids

The FDA issued a warning letter to McKesson for violations concerning a possible distribution of illegitimate opioid products while calling for action in securing the supply chain from illegitimate medications, especially opioids.


Esketamine nasal spray for ‘debilitating mental illness’ recommended for approval

US FDA Psychopharmacologic Drug Advisory Committee recommends Spravato, an intranasal form of esketamine, for approval based on its favorable benefit-risk profile.


Lonza collaborates on commercial supply manufacturing for anti-coagulation antidote

Portola and Lonza will collaborate on commercial supply the API for the formerâs anti-coagulation antidote at Lonzaâs facilities.


Lupin recalls 42 lots of antibiotic after contaminate found in vials

Lupin Pharmaceuticals voluntarily recalling lots of Ceftriaxone for Injection after rubber flecks were found in vials.


Almac expands neo-antigen peptide manufacturing

Almac announced it has increased its supply of neo-antigen peptides for individualized cancer treatments with the addition of another stream of GMP manufacturing.


2018: An inflection point for generics

Generics drug portfolios are diversifying, prices are stabilising, and while competition remains intense, the worst of price erosion appears to be over, claims Clarivate Analytics executive.


US FDA slams Korean OTC maker: All employees ‘lack knowledge of GMP requirements’

The US regulator has issued Barox a warning letter citing labelling, storage and quarantine violations in Seongnam, South Korea.


Sandoz’ EpiPen rival will launch in Q1, with lower price tag

Sandoz will launch its EpiPen generic in early 2019 at a lower price point than rival generics on the market.


Simpler drug delivery through capsule-based inhalation

Delivery by inhalation could be an easier way to deliver therapies in areas such as oncology, suggested ACGâs development manager.

Related Brands

Back to brands